Evidence-based cardiovascular therapies for patients with diabetes or metabolic syndrome
This session discusses the various approaches to treating patients with diabetes, including a discussion of guidelines from the American Heart Association, American College of Cardiology, American Diabetes Association and the American Association of Clinical Endocrinologists.
View Activity Information

Evidence-based cardiovascular therapies for patients with diabetes or metabolic syndrome

Participation and Successful Completion
Successful completion of this CE activity includes the following:

  1. Register and view the course online.
  2. View the content in its entirety.
  3. Complete a post-test with a minimum score of 100%.
  4. Complete a survey of your learning experience.
  5. Claim your CME/CE Certificate.


Hardware/Software Requirements
Internet Explorer 7 or greater, Firefox (Latest Version), Google Chrome, Windows 7 or above, Safari (Latest Version), Adobe Acrobat Reader, Internet Explorer is not supported on the Macintosh, Mac OS 10.4

Target Audience
Physicians - All CV Specialties                 
Nurses - All CV Specialties
EMS - All CV Specialties
Pharmacists - - All CV Specialties

Description
Type II diabetes is not just an elevated blood glucose that causes microvascular complications, but is also a major risk factor for cardiovascular complications, including sleep apnea, hypertension, atherosclerotic diseases, and several others.

This session discusses the various approaches to treating patients with diabetes, including a discussion of guidelines from the American Heart Association, American College of Cardiology, American Diabetes Association and the American Association of Clinical Endocrinologists.
 

Learning Objectives 
At the completion of this online course, the learner will be able to: 

  1. Translate emerging clinical science to clinical practice in patients with cardiovascular disease and stroke.

  2. Evaluate and implement new diagnostic and therapeutic strategies for treating cardiovascular disorders and stroke.

  3. Demonstrate an understanding of newly developed concepts in the care of patients with common cardiovascular problems including atrial fibrillation, hypertension, heart failure, and dyslipidemia.

  4. Describe treatment strategies for cardiovascular problems that can be deployed in the outpatient setting and keep patients out of the hospital.

  5. Describe treatment strategies for cardiovascular problems in the setting of common comorbidities.

  6. Describe the relative merits of new therapies for cardiovascular problems with respect to efficacy and cost.

 

Course Agenda

Topics

Objectives

Relation Between Diabetes and Cardiovascular Events

1, 3

Therapies for Individuals with Type 2 Diabetes and ASCVD Risk

1, 2, 4, 5, 6

Diabetes and Hypertension

1, 2, 3, 5

Cardiovascular Safety Studies involving DPP-4 Inhibitors

1, 3, 5

Interventions that Reduce CV Death in Patients with T2DM

1, 2, 3, 5

Comprehensive Management of Risk Factors in Patients with T2 Diabetes

1, 2, 3, 4, 5


Estimated Time to Complete the Educational Activity
44 minutes

Faculty
Mikhail Kosiborod, MD, FAHA
Professor of Medicine
Saint Luke’s Mid America Heart Institute
University of Missouri-Kansas City

Accreditation Statements
ORIGINAL RELEASE DATE:  03/14/2018
TERMINATION DATE:  03/14/2021
LAST REVIEW DATE: March 2018
JOINT ACCREDITATION TERM: 03/14/201803/14/2021

In support of improving patient care, this activity has been planned and implemented by the American Heart Association. The American Heart Association is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

AMA Credit Designation Statement - Physicians
The American Heart Association designates this live activity for a maximum of 0.75 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAPA Credit Acceptance Statement – Physician Assistants
AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 0.75 hours of Category 1 credit for completing this program.

AANP Credit Acceptance Statement – Nurse Practitioners
American Academy of Nurse Practitioners (AANP) accepts AMA PRA Category 1 CreditTM from organizations accredited by the ACCME.

ANCC Credit Designation Statement - Nurses
The maximum number of hours awarded for this CE activity is 0.75 contact hours.

ACPE Credit Designation Statement – Pharmacists
ACPE Credit: 0.75 Contact Hours.  Universal Program Number: JA0000134-0000-18-020-H04-P

Continuing Education Accreditation – Emergency Medical Services
This continuing education activity is approved by the American Heart Association, an organization accredited by the Commission on Accreditation of Pre-Hospital Continuing Education (CAPCE), for 0.75 Advanced CEHs, activity number 18-AMHA-F3-0022.

By claiming CAPCE credit, the claimant acknowledges the following: I understand that the American Heart Association as a requirement of CAPCE accreditation will submit a record of my course completions to the CAPCE AMS. I further understand that my course completion records may be accessed by or shared with such regulators as state EMS offices, training officers, and NREMT on a password-protected, need-to-know basis. In addition, I understand that I may review my record of CAPCE-accredited course completions by contacting CAPCE.

Disclosures
All persons who develop and/or control educational content in CME/CE activities provided by the American Heart Association will disclose to the audience all financial relationships with any commercial supporters of this activity as well as with other commercial interests whose lines of business are related to the CME/CE-certified content of this activity. In addition, presenters will disclose unlabeled/unapproved uses of drugs or devices discussed in their presentations. Such disclosures will be made in writing in course presentation materials.

Faculty Member

Employment

Research Grant

Consultant/
Advisory Board

Stock Shareholder (directly purchased)

Honoraria

Other

Speaker’s Bureau

Khurram Nasir

Baptist Health South Florida

None

None

None

None

None

Karol Watson

UCLA

None

Boehringer-Ingelheim, Amgen

None

None

Boehringer-Ingelheim

Kiran Musunuru

Univ of PA

None

None

None

None

None

Yuliya Krokhaleva

UCLA

None

None

None

None

None

Paul Wang

Stanford University

None

None

None

None

None

Mikhail Kosiborod

University of Missouri-Kansas City

AstraZeneca, Boehringer Ingelheim

Intarcia, Glytec, Novartis, AstraZeneca, Boehringer Ingelheim, Amgen, Sanofi, Janssen, Eisai, Novo Nordisk, Merck, ZS Pharma.

None

AstraZeneca, Boehringer Ingelheim, Novo Nordisk, Merck

None

Barbara Riegel

Univ of PA

Australian Catholic University

None

None

None

None

Michele Hamilton

Cedars-Sinai

None

None

None

None

None

This table represents the relationships of this educational activity’s faculty members that may be perceived as actual or reasonable perceived conflicts of interest as reported on the Disclosure Questionnaire which all AHA volunteers are required to complete and submit. The focus is on relevant financial relationships with commercial interests in the 12-month period preceding the time that the individual is being asked to assume a role controlling content.


Medium
This activity is an internet-based activity.

Contact Information
To contact the American Heart Association for any questions, please call our customer support center at 888-242-2453.
 

Policy on Privacy and Confidentiality
Please see the privacy link at the bottom of the Professional Education Center.
 

Copyright Information
Please see the link at the bottom of the Professional Education Center.
 

Commercial Support
This activity is supported by independent medical educational grants from Pfizer, Merck, Chiesi, Amarin, Amgen, and Aegerion.

Type:  Internet Activity (Enduring Material)
$8.00
Members Price
$10.00
Non-members Price
8 Registered Users
Credits
0.75 Credits> Accreditation Council for Continuing Medical Education> AMA PRA Category 1 Credit

0.75 Contact Hours> Accreditation Council for Pharmacy Education> ACPE

0 Credits> American Heart Association> AHA

0.75 Contact Hours> American Nurses Credentialing Center> ANCC

0.75 Credits> Accreditation Council for Continuing Medical Education> Attendance Credit

0.75 CEH> CAPCE> CAPCE Advanced